Focus on Facial Aesthetics
Clinical Studies and Experience With Bimatoprost and Botulinum Toxin Type A

 

This CME supplement to Skin & Allergy News is supported by Allergan Dermatology and is based on presentations made at Skin Disease Education Foundation's 33rd Annual Hawaii Dermatology SeminarTM.

• Topic Highlights
• Faculty/Faculty Disclosures

 

To view the supplement, click the image above.

 

Topic Highlights

• Topical Prostaglandin Treatment for Hypotrichosis: Overview of the Clinical Data
• Botulinim Toxin Type A Injectables: A Critical View of Similarities and Differences
Faculty/Faculty Disclosures

Dee Anna Glaser, MD
Professor and Vice Chairman
Department of Dermatology
Saint Louis University
St Louis, MO
Dr Glaser is a consultant for Allergan.

 

 

Mark G. Rubin, MD
Associate Professor of Dermatology
University of California, San Diego
San Diego, CA
Dr Rubin is a consultant for Medicis.

 

Copyright © 2009 by Elsevier Inc.

---